Palaiseau, France

Olivier Lavergne

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Massy, FR (1999 - 2006)
  • Palaiseau, FR (2002 - 2019)

Company Filing History:


Years Active: 1999-2019

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Olivier Lavergne

Introduction

Olivier Lavergne, located in Palaiseau, France, is an accomplished inventor with a remarkable portfolio that includes 18 patents. His work significantly contributes to the fields of medicine and biotechnology, showcasing his dedication to advancing scientific knowledge and developing new therapies for various diseases.

Latest Patents

Among his latest innovations, Lavergne has patented macrocyclic LRRK2 kinase inhibitors. This invention focuses on novel macrocyclic compounds that act as kinase inhibitors, particularly targeting the LRRK2 protein. These compounds hold great promise for treating and diagnosing diseases associated with LRRK2 kinase activity, including neurological disorders such as Parkinson's disease and Alzheimer's disease.

Another noteworthy patent is for substituted biphenyl analogues, which serve as dual inhibitors of aromatase and sulfatase. These new biphenyl derivatives are designed to combat hormone-dependent cancers by inhibiting the activities of aromatase and sulfatase. The invention also includes methods for preparing these compounds and pharmaceutical compositions useful for treating related diseases.

Career Highlights

Olivier Lavergne has built his career at reputable organizations, including the Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS) and the Société de Recherches et d'Applications Scientifiques. His experience in these companies has provided him with a solid foundation in research and development, allowing him to thrive as an inventor.

Collaborations

Throughout his career, Lavergne has collaborated with notable colleagues, including Dennis Bigg and Christophe Lanco. These partnerships have likely enriched his research efforts and contributed to the innovative solutions he continues to develop.

Conclusion

Olivier Lavergne stands out as a prominent inventor with significant contributions to medical and biochemical innovations. His extensive patent portfolio reflects his dedication to creating effective treatments for critical health conditions. With ongoing work in kinase inhibitors and hormonal therapies, Lavergne's innovations promise to influence the future of medicine positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…